30207554Robinson JG, Davidson MHReviews in cardiovascular medicineAnticholesteremic Agents; Atherosclerosis; Cholesterol, LDL; DyslipidemiasApolipoprotein B-100; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; PCSK9 Inhibitors; Plaque, Atherosclerotic; Proprotein Convertase 9; Randomized Controlled Trials as Topic; Research Design; Serine Proteinase Inhibitors; Time Factors; Treatment OutcomeCan We Cure Atherosclerosis? Rev Cardiovasc Med. 2018; 19(S1):S20-S24.Rev Cardiovasc Med2018-01-01T00:00:002018Can We Cure Atherosclerosis?prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD004359Procedures2748930.819213Drug Therapy, CombinationAuthorship 11952020.6488890.6488891authors10.2517has subject areaD006801Living Beings2262862810.130064HumansD013997Concepts & Ideas118351980.519664Time FactorsD015415Concepts & Ideas59717090.619611BiomarkersD008078Chemicals & Drugs502220.890104Cholesterol, LDLD016032Concepts & IdeasProcedures2778500.730148Randomized Controlled Trials as TopicD016896Concepts & Ideas101179490.402421Treatment OutcomeD050197Disorders732430.782454AtherosclerosisD019161Chemicals & Drugs893780.727265Hydroxymethylglutaryl-CoA Reductase InhibitorsD053299Chemicals & Drugs6120.996851Apolipoprotein B-100D012107Concepts & IdeasLiving BeingsProcedures2505940.748878Research DesignD050171Disorders341090.88472DyslipidemiasD015842Chemicals & Drugs17280.979986Serine Proteinase InhibitorsD058226AnatomyDisorders25540.931427Plaque, AtheroscleroticD000924Chemicals & Drugs221370.888003Anticholesteremic AgentsD00007144910200.986554Proprotein Convertase 9D004334Concepts & Ideas2609160.852436Drug Administration ScheduleUniversity of ChicagoMichael H.DavidsonMichael H. Davidson41.78927490000000-87.60125000000000611Davidson, Michael H.Clinical Professortrue1Clinical ProfessorClinical ProfessorMedicine-Cardiology